Position in ARGX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,431,549
+$571,315 QoQ
Shares Held
1,543
+31.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#223
of 505 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $29,990,834 across 34 Biotechnology names. ARGX ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,721 | $16,750,232 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,663 | $2,087,523 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,437 | $1,519,566 | |
| 4 | ARGX |
Argenx SE
This page
|
1,543 | $1,431,549 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,542 | $755,877 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
3,115 | $583,377 | |
| 7 | MRNA |
Moderna, Inc.
|
7,765 | $543,782 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
3,712 | $455,016 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,431,549 | 1,543 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $860,234 | 1,178 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,057,915 | 1,258 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $556,857 | 755 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $374,650 | 633 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $303,810 | 494 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||